Avacta Group Plc (LON:AVCT – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 43.55 ($0.54) and last traded at GBX 44.60 ($0.55), with a volume of 6176707 shares traded. The stock had previously closed at GBX 48.50 ($0.60).
Avacta Group Stock Performance
The company has a debt-to-equity ratio of 225.41, a quick ratio of 4.96 and a current ratio of 0.71. The stock’s 50 day moving average price is GBX 59.46 and its 200 day moving average price is GBX 101.32. The company has a market capitalization of £158.43 million, a P/E ratio of -278.13 and a beta of 1.21.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
See Also
- Five stocks we like better than Avacta Group
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Technologies to Challenge NAND Flash Dominance in AI
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Is Zoom Video Stock Getting Too Cheap to Pass Up?
- How to Invest in Small Cap Stocks
- Packaging Corporation of America: Buy The Dip
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
